Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion type Assertion NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_head.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion description "[We have examined expression of the components of the plasminogen activation system in human astrocytoma U373-MG cells and found that interleukin 1beta (IL-1beta), tumour necrosis factor alpha TNF-alpha), interferon gamma (INF-gamma) and epidermal growth factor (EGF) specifically regulate the expression of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), plasminogen activator inhibitor type 1 (PAI-1) and protease nexin-1 (PN-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_provenance.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion evidence source_evidence_literature NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_provenance.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion SIO_000772 11814314 NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_provenance.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion wasDerivedFrom befree-20140225 NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_provenance.
- NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_assertion wasGeneratedBy ECO_0000203 NP597721.RApw81rGBtilZ9gaEA8LX37XVGCnUQ3HvDG2INpG-EfEA130_provenance.